Legal & General Group Plc lessened its holdings in Waters Co. (NYSE:WAT - Free Report) by 21.0% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 423,098 shares of the medical instruments supplier's stock after selling 112,237 shares during the quarter. Legal & General Group Plc owned approximately 0.71% of Waters worth $156,961,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors have also bought and sold shares of WAT. Wealthfront Advisers LLC increased its stake in Waters by 106,144.4% in the 4th quarter. Wealthfront Advisers LLC now owns 3,087,461 shares of the medical instruments supplier's stock worth $1,145,386,000 after buying an additional 3,084,555 shares during the period. Norges Bank purchased a new position in shares of Waters during the fourth quarter worth approximately $284,415,000. Madison Investment Advisors LLC purchased a new position in shares of Waters during the fourth quarter worth approximately $104,645,000. Principal Financial Group Inc. raised its stake in shares of Waters by 70.7% during the third quarter. Principal Financial Group Inc. now owns 656,019 shares of the medical instruments supplier's stock valued at $236,095,000 after acquiring an additional 271,804 shares in the last quarter. Finally, Alliancebernstein L.P. grew its stake in Waters by 8.7% in the fourth quarter. Alliancebernstein L.P. now owns 2,654,002 shares of the medical instruments supplier's stock worth $984,582,000 after purchasing an additional 212,364 shares in the last quarter. Hedge funds and other institutional investors own 94.01% of the company's stock.
Wall Street Analysts Forecast Growth
A number of equities research analysts have weighed in on WAT shares. JPMorgan Chase & Co. lifted their target price on Waters from $380.00 to $390.00 and gave the company a "neutral" rating in a research report on Thursday, March 6th. KeyCorp upgraded shares of Waters from a "sector weight" rating to an "overweight" rating and set a $460.00 target price on the stock in a report on Monday, March 31st. StockNews.com lowered shares of Waters from a "buy" rating to a "hold" rating in a report on Tuesday, February 25th. Baird R W raised shares of Waters from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, March 26th. Finally, Sanford C. Bernstein raised shares of Waters from a "market perform" rating to an "outperform" rating and set a $430.00 price objective for the company in a research note on Friday, January 10th. Ten analysts have rated the stock with a hold rating, seven have given a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat.com, Waters has a consensus rating of "Moderate Buy" and a consensus target price of $397.25.
View Our Latest Report on WAT
Waters Stock Performance
Shares of Waters stock traded down $9.76 on Tuesday, reaching $324.01. 138,174 shares of the stock were exchanged, compared to its average volume of 517,923. Waters Co. has a twelve month low of $279.24 and a twelve month high of $423.56. The company has a quick ratio of 0.65, a current ratio of 0.94 and a debt-to-equity ratio of 1.14. The firm has a market capitalization of $19.25 billion, a price-to-earnings ratio of 30.25, a PEG ratio of 3.79 and a beta of 1.04. The business has a 50 day moving average price of $367.21 and a two-hundred day moving average price of $372.32.
Waters (NYSE:WAT - Get Free Report) last issued its earnings results on Wednesday, February 12th. The medical instruments supplier reported $4.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.02 by $0.08. Waters had a net margin of 21.56% and a return on equity of 46.31%. Analysts anticipate that Waters Co. will post 12.86 earnings per share for the current fiscal year.
Waters Company Profile
(
Free Report)
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Featured Articles
Before you consider Waters, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waters wasn't on the list.
While Waters currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
